Glucose Measurement Using Microneedle Patches
- Conditions
- Diabetes
- Interventions
- Device: Microneedle patchDevice: Intravenous (IV) catheterDevice: Lancet
- Registration Number
- NCT02682056
- Lead Sponsor
- Emory University
- Brief Summary
This study will compare three glucose measurement techniques among diabetic children and adolescents. The study seeks to determine if a microneedle patch (made from biocompatible polymers or metal), versus a lancet or intravenous catheter, would be a preferable option for monitoring glucose levels among the diabetic pediatric population.
- Detailed Description
Fifteen children and adolescents with diabetes will be tested for their glucose measurements comparing interstitial fluid collected via a microneedle patch (made from biocompatible polymers or metal), versus the standard of care blood sample (lancet), and lab grade blood draw (intravenous catheter). Samples will be taken hourly from all three devices for four hours. All four measurements will be compared against each other to see how close they are with measuring the glucose values. Each participant will be asked to rate their apprehension prior to receiving each method for blood or interstitial fluid collection as well as the pain associated with each method immediately after collection.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
- Diabetes diagnosis
- no exclusion criteria are specified
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Single Study Arm Intravenous (IV) catheter Children and adolescents with diabetes will have blood glucose levels tested using microneedle patches, intravenous (IV) catheter draw, and lancet. Single Study Arm Lancet Children and adolescents with diabetes will have blood glucose levels tested using microneedle patches, intravenous (IV) catheter draw, and lancet. Single Study Arm Microneedle patch Children and adolescents with diabetes will have blood glucose levels tested using microneedle patches, intravenous (IV) catheter draw, and lancet.
- Primary Outcome Measures
Name Time Method Glucose Level Baseline (Hour 1), Hour 2, Hour 3, Hour 4 Participants had their glucose levels tested through three different methods. Interstitial glucose levels was assessed using a microneedles patch. Blood glucose levels were collected via the lancet and intravenous (IV) collection methods.
- Secondary Outcome Measures
Name Time Method Apprehension Level Assessed by Apprehension Visual Analog Scale (VAS) Baseline ( Hour 1), Hour 4 Participants completed a Visual Analog Scale (VAS) to report the level of apprehension they felt regarding each method of sample collection. Participants will mark on a line scale (between not afraid and very afraid) to indicate fear level when a sample is collected. The range is from 0-100 mm with 0 mm indicating no apprehension and 100 mm indicating the most apprehension.
Pain Level Assessed by Pain Visual Analog Scale (VAS) Baseline ( Hour 1), Hour 4 Participants completed a Visual Analog Scale (VAS) to report the level of pain they felt regarding each method of sample collection. Participants marked on a line scale (between no pain and worst pain ever) to indicate pain level when a sample is collected. The range is from 0-100 mm with 0 mm indicating no pain and 100 mm indicating the most extreme pain.
Trial Locations
- Locations (2)
Children's Healthcare of Atlanta
🇺🇸Atlanta, Georgia, United States
Emory Children's Center
🇺🇸Atlanta, Georgia, United States